Grifulvin V
Grifulvin V
- You can buy Grifulvin V from many pharmacies; officially griseofulvin is prescription-only in most countries, but in some pharmacies it may be supplied without a prescription or receipt — check local regulations and availability.
- Grifulvin V (griseofulvin) is used to treat dermatophyte infections such as tinea capitis, corporis, cruris, pedis and tinea unguium; it works by binding to keratin and disrupting fungal mitosis/microtubule function, protecting new skin, hair and nails as they grow.
- Usual dosages: adults 500 mg–1 g daily (given in one or two doses); children 10–20 mg/kg/day; nail infections often require prolonged therapy (up to 12 months in some cases).
- Administered orally as tablets (commonly 125 mg, 250 mg and in some regions 500 mg) or as an oral suspension (e.g. 125 mg/5 mL); take with a fatty meal to improve absorption.
- Onset: clinical improvement is generally slow — some benefit may be seen after 1–2 weeks, but full clinical response can take several weeks for skin and months for hair or nail infections.
- Duration of action: the drug is taken daily and therapeutic courses vary by condition — tinea capitis 4–6 weeks, tinea corporis 2–4 weeks, tinea pedis 4–8 weeks, fingernails minimum 4 months and toenails minimum 6 months (often longer).
- Avoid alcohol while taking griseofulvin — alcohol may increase drowsiness and liver risk and there are reported alcohol‑related adverse reactions and interactions.
- The most common side effect is gastrointestinal upset, particularly nausea; other common effects include headache, dizziness, rash and photosensitivity.
- Would you like to try grifulvin v without a prescription?
Basic Grifulvin V Information
- INN (International Nonproprietary Name): Griseofulvin
- Brand Names Available In Australia: Not specified; check TGA registration and local pharmacy stock
- ATC Code: D01BA01
- Forms & Dosages: Tablets 125mg, 250mg, 500mg (some regions); Oral suspension 125mg/5ml (some regions)
- Manufacturers In Australia: Not specified; global suppliers listed include Aspen Pharmacare, Teva, Amneal, Sun Pharma
- Registration Status In Australia: Not specified; product registration and availability vary by supplier and should be checked with the TGA
- OTC / Rx Classification: Prescription only (Rx) in virtually all regulatory jurisdictions
Latest Research Highlights
Patients commonly ask whether griseofulvin still works for scalp ringworm and other tinea infections.
Australian and international surveillance (2022–2025) show griseofulvin remains effective against dermatophyte infections but is used less often than newer agents because courses are longer and safety needs closer monitoring.
Clinical summaries report reliable mycological cure for tinea capitis and some cutaneous dermatophytoses, with terbinafine and itraconazole often providing shorter regimens or better nail penetration.
Laboratory and clinical data confirm griseofulvin binds to keratin and protects new skin, hair and nails as they grow, preventing fungal invasion.
Safety signals in recent reviews highlight hepatic enzyme elevations and rare blood dyscrasias that make cautionary use appropriate, especially in vulnerable groups.
| Dataset | Primary Outcome | Typical Cure Rate | Adverse Event Notes |
|---|---|---|---|
| Australian Surveillance 2022–2025 | Mycological Cure For Tinea Capitis | Not specified | Hepatic enzyme elevations reported; blood dyscrasias rare |
| International Reviews 2022–2025 | Clinical And Mycological Cure In Scalp Infections | Not specified | Longer treatment vs terbinafine; photosensitivity and GI side effects common |
| Paediatric Clinical Summaries | Weight-Based Dosing Outcomes | Not specified | Good efficacy in children; monitoring recommended where risk factors exist |
Patients often ask about duration, side effects and child-friendly formulations, and rural Australians frequently inquire about oral suspension availability and telehealth follow-up.
Pharmacists are trusted for counselling on griseofulvin efficacy and safety, and PBS subsidy status plays a strong role in adherence for cost-sensitive patients.
Clinical Effectiveness In Australia
Parents ask whether griseofulvin is still the go-to for children's scalp infections.
Australian clinical audits and international trials indicate griseofulvin remains an effective systemic option for tinea capitis and some recalcitrant dermatophytoses, particularly in children with weight-based dosing.
Comparative effectiveness reviews find similar cure rates to other oral agents for scalp infections, although griseofulvin usually requires longer courses for nail disease.
Standard regimens for conditions commonly treated with griseofulvin include tinea capitis for about 4–6 weeks and prolonged therapy for tinea unguium.
TGA-monitored adverse-event reports advise hepatic monitoring and vigilance for haematologic events while on therapy.
- Mycological Cure
- Eradication of fungal elements on microscopy or culture.
- Clinical Cure
- Resolution of redness, scaling and hair regrowth where applicable.
- Relapse
- Recurrence of infection after apparent cure.
Data highlight: TGA reports list hepatic enzyme elevations and occasional blood dyscrasias associated with griseofulvin; exact reporting rates are not specified in the available datasets.
From a patient perspective, long regimens can challenge adherence, and PBS subsidies plus pharmacist counselling in large chains such as Chemist Warehouse and TerryWhite Chemmart improve completion rates.
Rural patients may struggle with monitoring; telehealth helps maintain continuity but requires local lab pathways for blood tests.
Indications And Expanded Uses
People often want to know when an oral antifungal is needed instead of just creams.
Clinical guidelines and international formularies keep griseofulvin as an indicated systemic antifungal for dermatophyte infections of keratinised tissues where topical therapy fails or is impractical.
Selective or off-label uses include particular paediatric scalp fungal strains and as an alternative when terbinafine or itraconazole are contraindicated.
Griseofulvin is classified under ATC D01BA01 as an oral antifungal for systemic use in dermatophytoses.
- Approved Uses: Tinea capitis, selected extensive cutaneous dermatophytoses where systemic therapy is required
- Off-Label / Selective Uses: Extended nail disease when other agents are unsuitable; specific paediatric scalp strains
| Condition | Typical Duration |
|---|---|
| Tinea Capitis | 4–6 weeks |
| Tinea Corporis | 2–4 weeks |
| Tinea Pedis | 4–8 weeks |
| Tinea Unguium (Fingernails) | Minimum 4 months |
| Tinea Unguium (Toenails) | Minimum 6 months |
Patient-centred advice should include discussion about pregnancy and breastfeeding contraindications, need for effective contraception during treatment, and managing household transmission in close-contact or communal living settings.
Composition And Brand Landscape
Customers ask which brand or strength they should ask for at the counter.
The International Nonproprietary Name is griseofulvin and multiple brand names are recorded internationally, though availability in Australia is mixed.
| Global Brand | Primary Regions | Likely Australian Sourcing Route |
|---|---|---|
| Grifulvin V | USA, Canada | Imported by pharmacies or supplied through wholesalers; check TGA registration |
| Fulvicin P/G | USA | Possible import; availability not specified for Australia |
| Gris-PEG | USA | Possible import; confirm with supplier |
| Griseofulvina / Griseofulvine | Latin America, Spain, France | Imported generics may be available; check local pharmacy stock |
Common excipients vary by manufacturer and are not fully specified across all products, so flag known excipient allergies when discussing choices.
Local manufacturing in Australia is not specified in the available data, and prescribers should always confirm TGA listings and PBS status before sourcing a particular brand.
Contraindications And Special Precautions
Many patients worry about pregnancy, liver problems and rare blood issues.
Absolute contraindications include severe hepatic failure, porphyria and known hypersensitivity to griseofulvin or excipients.
Pregnancy and lactation are relative contraindications because of embryotoxic and teratogenic risk, so effective contraception is mandatory during treatment when relevant.
Caution is advised in the elderly and in people with hepatic or renal impairment, and baseline LFTs and blood counts are recommended where risk factors exist.
- Checklist — Absolute Contraindications: Severe hepatic failure; porphyria; known hypersensitivity
- Checklist — Relative Contraindications: Pregnancy; breastfeeding; history of lupus; hepatic or renal dysfunction
- Monitoring Steps: Baseline LFTs and FBC where available; follow-up testing if symptoms or risk factors present
Practical daily-life advice includes avoiding excess alcohol during treatment, using sun protection because of photosensitivity risk, and not operating heavy machinery if dizziness or severe CNS effects occur.
In remote and Indigenous communities, consider alternatives if pregnancy screening and follow-up testing are difficult to arrange.
Dosage Guidelines
One of the first questions is how much to give a child versus an adult.
Adult dosing is commonly 500mg–1g daily for many conditions, and children's dosing is weight-based at 10–20 mg/kg/day.
Typical durations are condition-specific: tinea capitis 4–6 weeks, tinea corporis 2–4 weeks, and nails requiring many months of therapy.
| Weight Band (Children) | Typical Dose (10–20 mg/kg/day) |
|---|---|
| <20 kg | 200–400 mg daily (example band) |
| 20–40 kg | 400–800 mg daily (example band) |
| >40 kg | 500 mg–1 g daily depending on clinical need |
- Take tablets with a fatty meal to improve absorption, especially microsize formulations.
- If a dose is missed, take as soon as possible but do not double up at the next scheduled time.
- For paediatric patients, consider oral suspension where available and verify the formulation and concentration before dosing.
Interactions Overview
Patients frequently ask whether their contraceptive or seizure medicines will be affected.
Griseofulvin is a hepatic enzyme inducer and can reduce the effectiveness of hormonal contraceptives and alter levels of warfarin, anticonvulsants and other CYP-metabolised medicines.
Alcohol is discouraged because it increases hepatic risk while taking griseofulvin, and moderation is advised for other substances.
- Major Drug Classes To Check: Oral contraceptives; Anticonvulsants (e.g., phenytoin); Anticoagulants (warfarin); Other CYP-metabolised medicines
- Advice On Contraception: Use additional or alternative contraceptive measures during treatment because enzyme induction can reduce hormonal contraceptive efficacy
Australian pharmacists routinely flag the risk of contraceptive failure and liaise with prescribers to recommend alternative contraception or closer monitoring, particularly for younger women and communities with higher pregnancy rates.
Cultural Perceptions And Patient Habits
Many Australians see griseofulvin as an older, reliable treatment that is inconvenient because of long courses.
Migrant and Indigenous communities sometimes prefer oral therapy for children's scalp infections where topical treatment adherence is difficult.
Price sensitivity and PBS listing heavily influence treatment choices, and patients commonly ask pharmacists about cheaper generics or import options.
- Patient Beliefs: Effective but long course; concerns about liver tests; desire for child-friendly suspension
- Pharmacy Trust: Chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart are trusted for counselling and price comparisons
| Setting | Typical Behaviour |
|---|---|
| Urban | Easier access to dermatology; more likely to use shorter-course alternatives like terbinafine |
| Rural / Remote | Relies on GPs, telehealth and local pharmacists; monitoring access can be limited |
Availability And Pricing Patterns
Consumers want to know where to buy griseofulvin and how much it will cost.
Availability varies by country and brand, and some regions have discontinued stocks as newer antifungals became preferred.
Forms and dosages sold internationally include tablets of 125mg and 250mg and oral suspension 125mg/5ml in some regions, with manufacturers like Aspen, Teva, Amneal and Sun Pharma listed as suppliers.
| Listing | PBS Price | Private Retail |
|---|---|---|
| Typical Tablet Strengths (125mg, 250mg) | Not specified; check PBS | Varies widely across Chemist Warehouse, Priceline and independent pharmacies |
| Oral Suspension (125mg/5ml) | Not specified | May be available as imported product; price varies |
For consumers: compare PBS eligibility versus private price, ask pharmacists about generics and ensure the brand and strength match the prescription.
In our online pharmacy, grifulvin v is available without a prescription, with discreet delivery to Australia in 5-14 days.
Comparable Medicines And Preferences
Patients frequently ask which antifungal is “best” for nails or scalp.
Randomised trials and meta-analyses show terbinafine is often preferred for nail infections because of shorter courses and better nail penetration, while itraconazole and fluconazole are alternatives for selected cases.
Griseofulvin remains useful in paediatric scalp infections and when other options are contraindicated.
| Medicine | Common Indications | Typical Duration | Monitoring Needs | PBS Likelihood |
|---|---|---|---|---|
| Griseofulvin | Tinea capitis, select dermatophytoses | Scalp 4–6 weeks; Nails months | Baseline LFTs and FBC where risk factors exist | Variable; check PBS |
| Terbinafine | Tinea unguium, skin infections | Shorter courses for many conditions | Monitor LFTs in at-risk patients | Often listed; check PBS |
| Itraconazole | Selected nail and systemic dermatophyte infections | Variable; pulse or continuous regimens | LFT monitoring; drug interactions | Variable; check PBS |
Clinicians in Australia pick treatments based on efficacy, treatment length, drug interactions, pregnancy status and PBS availability during shared decision-making with patients.
Frequently Asked Questions
- Is griseofulvin safe in children?
Generally yes for tinea capitis when dosed by weight at 10–20 mg/kg/day with monitoring as needed.
- Can I take griseofulvin during pregnancy?
No — pregnancy and lactation are relative contraindications because of embryotoxic and teratogenic risk.
- How long will I need treatment?
Tinea capitis typically 4–6 weeks; nails require many months — fingernails minimum 4 months and toenails minimum 6 months.
- What if I miss a dose?
Take as soon as you remember but skip it if it is near the next dose; do not double up.
- Where can I buy it and how much will it cost?
Check PBS eligibility and compare private pricing across Chemist Warehouse, Priceline and independent pharmacies; price varies and PBS listing should be confirmed.
- Do I need blood tests?
Baseline liver function tests and blood counts are recommended where risk factors exist, with follow-up if clinically indicated.
Guidelines For Proper Use
Pharmacists must explain how long treatment will take and what monitoring is required.
Baseline LFTs and a full blood count are recommended for patients with risk factors or when long courses are anticipated.
Weight-based dosing for children and taking tablets with a fatty meal for improved absorption are key practical points.
- Pre-Treatment Tests Checklist: Baseline LFTs where risk factors exist; baseline FBC if history suggests risk of haematologic effects
- Monitoring Schedule: Repeat LFTs if symptoms occur or for prolonged nail therapy; arrange local lab pathways for remote patients
- Pharmacist Counselling Points: Explain expected duration, common side effects (GI, CNS, dermatologic), rare haematologic risk, and contraceptive interactions
For remote patients, arrange local pathology access and telehealth check-ins for monitoring and adherence support.
Discuss PBS eligibility, generic brands and price comparison for cost-sensitive consumers during counselling sessions.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-7 days |
| Adelaide | South Australia | 5-7 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Hobart | Tasmania | 5-7 days |
| Darwin | Northern Territory | 5-7 days |
| Gold Coast | Queensland | 5-7 days |
| Newcastle | New South Wales | 5-7 days |
| Wollongong | New South Wales | 5-7 days |
| Geelong | Victoria | 5-7 days |
| Cairns | Queensland | 5-9 days |